Holen Sie sich die Stockscreener-App
13.94
0.94%
0.1488
Schlusskurs vom Vortag:
$13.79
Offen:
$13.97
24-Stunden-Volumen:
223.57K
Relative Volume:
0.08
Marktkapitalisierung:
$1.46B
Einnahmen:
$64.52M
Nettoeinkommen (Verlust:
$-95.55M
KGV:
-13.71
EPS:
-1.0169
Netto-Cashflow:
$-84.65M
1W Leistung:
+10.56%
1M Leistung:
+24.96%
6M Leistung:
+77.32%
1J Leistung:
+85.48%
1-Tages-Spanne:
$13.86
$14.24
1-Wochen-Bereich:
$12.26
$14.24
52-Wochen-Spanne:
$3.84
$14.24
Personalis Inc Stock (PSNL) Company Profile
Firmenname
Personalis Inc
Sektor
Branche
Telefon
650-752-1300
Adresse
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL vs TMO, DHR, IDXX, NTRA, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
13.90 | 1.40B | 64.52M | -95.55M | -84.65M | -1.0169 |
TMO
Thermo Fisher Scientific Inc
|
522.40 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
195.56 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
542.15 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
276.49 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
133.56 | 37.52B | 7.23B | 1.41B | 1.09B | 4.979 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-03-17 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-06 | Hochstufung | Needham | Hold → Buy |
| 2022-01-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Herabstufung | Needham | Buy → Hold |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-20 | Bestätigt | Needham | Buy |
| 2021-05-06 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-12 | Bestätigt | Needham | Buy |
| 2020-11-06 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Eingeleitet | Citigroup | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-08-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-07-15 | Eingeleitet | Cowen | Outperform |
| 2019-07-15 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-07-15 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Personalis Inc Aktie (PSNL) Neueste Nachrichten
Personalis CFO and COO Aaron Tachibana sells $69,748 of stock. - Investing.com UK
Personalis CFO and COO Aaron Tachibana sells $69,748 of stock. By Investing.com - Investing.com India
Form 4 Personalis Inc For: 29 June By Investing.com - Investing.com Canada
Personalis (PSNL) CFO trades 4,982 shares under Rule 10b5-1 plan - Stock Titan
PSNL (NASDAQ: PSNL) files Rule 144 to sell 4,982 shares via option exercise - Stock Titan
Personalis Inc. (PSNL) Shares Surge Over 5% as Momentum Builds Near Key ResistanceGap and Go - dars.gov.et
Personalis, Inc. Actuals & Estimates (SWB:04X) - TradingView
PSNL Technical Analysis & Stock Price Forecast - Intellectia AI
Form 144 Personalis For: 26 June By Investing.com - Investing.com Australia
Personalis CFO Aaron Tachibana sells $675,488 in company stock By Investing.com - Investing.com Nigeria
Personalis Inc (PSNL) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Form 4 Personalis Inc For: 26 June By Investing.com - Investing.com Nigeria
Personalis CEO Christopher Hall sells $1.31m in company stock By Investing.com - Investing.com Nigeria
Personalis CEO Christopher Hall sells $1.31m in company stock - Investing.com
Personalis CFO Aaron Tachibana sells $675,488 in company stock - Investing.com UK
Personalis | 4: Statement of changes in beneficial ownership of securities-Officer Tachibana Aaron - Moomoo
Personalis (PSNL) CFO uses 10b5-1 plan to exercise options and sell shares - Stock Titan
Personalis (PSNL) CEO sells 100K shares after exercising options - Stock Titan
PSNL: Form 144 lists 51,251 shares to be sold; prior 10b5-1 sales noted - Stock Titan
Broker files Form 144 as Christopher Hall sells 100,000 PSNL shares (PSNL) - Stock Titan
Personalis, Inc. Actuals & Estimates (MUN:04X) - TradingView
Personalis, Inc. Actuals & Estimates (NASDAQ:PSNL) - TradingView
PSNL Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Personalis, Inc. – NASDAQ:PSNL - TradingView
Why Personalis Stock Is Rising: Medicare Covers Lung Cancer MRD Test - Stocktwits
Personalis stock hits 52-week high at 12.53 USD By Investing.com - Investing.com South Africa
Personalis stock hits 52-week high at 12.53 USD - Investing.com
Personalis Inc (PSNL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Personalis Inc (PSNL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Numerous Personalis Insiders Sold Stock: Not A Positive Omen - 富途牛牛
Q1 2026 Personalis Inc Earnings Call Transcript - GuruFocus
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Personalis Inc (PSNL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Personalis Inc (PSNL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Personalis Inc (PSNL) Institutional Confidence - TradingKey
Personalis Inc (PSNL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Personalis Inc (PSNL) Valuation: PE, PB & Fair Value Analysis - TradingKey
PSNL Q1 2026 Earnings: EPS Misses Estimates, Stock Declines on Weak ResultsRetail Earnings Report - newsline.com
Personalis (NASDAQ: PSNL) director receives 6,250 RSU award in Form 4/A update - Stock Titan
Lightspeed funds (NASDAQ: PSNL) report 5.8% Personalis stake after in-kind distributions - Stock Titan
Personalis Inc. (PSNL) Q1 2026 Earnings: Loss Wider Than Expected, Stock DipsPost-Announcement Reaction - newsline.com
Personalis blood collection kits receive EU regulatory approval - Investing.com UK
Personalis (PSNL) Receives CE Mark Approval for Blood Collection Kits - GuruFocus
Personalis Gains EU Approval for Blood Collection Kits Used in Genomic Testing - Moomoo
Personalis blood collection kits receive EU regulatory approval By Investing.com - Investing.com Nigeria
Finanzdaten der Personalis Inc-Aktie (PSNL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):